MFDS — authorised 18 June 1959
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Status: likely_approved
🇰🇷 Depo-Provera in South Korea
MFDS authorised Depo-Provera on 18 June 1959
Marketing authorisation
Depo-Provera in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Depo-Provera approved in South Korea?
Yes. MFDS authorised it on 18 June 1959.
Who is the marketing authorisation holder for Depo-Provera in South Korea?
PHARMACIA AND UPJOHN holds the South Korean marketing authorisation.